✉ Email this page to a colleague
« Back to Dashboard
Probuphine is a drug marketed by Titan Pharms and is included in one NDA. There is one patent protecting this drug.
This drug has sixteen patent family members in thirteen countries.
The generic ingredient in PROBUPHINE is buprenorphine hydrochloride. There are twenty-nine drug master file entries for this compound. Nineteen suppliers are listed for this compound. Additional details are available on the buprenorphine hydrochloride profile page.
A generic version of PROBUPHINE was approved as buprenorphine hydrochloride by HOSPIRA on June 3rd, 1996.
Summary for PROBUPHINE
|Raw Ingredient (Bulk) Api Vendors:||12|
|Formulation / Manufacturing:||see details|
|Drug Prices:||Drug price information for PROBUPHINE|
|What excipients (inactive ingredients) are in PROBUPHINE?||PROBUPHINE excipients list|
|DailyMed Link:||PROBUPHINE at DailyMed|
Recent Clinical Trials for PROBUPHINE
Identify potential brand extensions & 505(b)(2) entrants
|Medical College of Wisconsin||Phase 2|
|Braeburn Pharmaceuticals||Phase 3|
|National Institute on Drug Abuse (NIDA)||Phase 3|
|Applicant||Tradename||Generic Name||Dosage||NDA||Approval Date||TE||Type||RLD||RS||Patent No.||Patent Expiration||Product||Substance||Delist Req.||Exclusivity Expiration|
|Titan Pharms||PROBUPHINE||buprenorphine hydrochloride||IMPLANT;IMPLANTATION||204442-001||May 26, 2016||DISCN||Yes||No||See Plans and Pricing||See Plans and Pricing||See Plans and Pricing|
|>Applicant||>Tradename||>Generic Name||>Dosage||>NDA||>Approval Date||>TE||>Type||>RLD||>RS||>Patent No.||>Patent Expiration||>Product||>Substance||>Delist Req.||>Exclusivity Expiration|
See the table below for patents covering PROBUPHINE around the world.
|Country||Patent Number||Title||Estimated Expiration|
|Japan||4668611||See Plans and Pricing|
|Japan||2005528422||See Plans and Pricing|
|European Patent Office||1509182||DISPOSITIF POLYMERE IMPLANTABLE PERMETTANT LA LIBERATION PROLONGEE DE BUPRENORPHINE (IMPLANTABLE POLYMERIC DEVICE FOR SUSTAINED RELEASE OF BUPRENORPHINE)||See Plans and Pricing|
|>Country||>Patent Number||>Title||>Estimated Expiration|